IONS
Ionis Pharmaceuticals, Inc. · Healthcare
EVP and Chief Development Officer Holly B. Kordasiewicz sold $4.5M of Ionis Pharmaceuticals, Inc.
Sold$4,466,428
$73.41Price
60,846Shares
−73%Stake
What IONS did after the filing
- The stock from Wed, Jun 17 open, $73.09
- −29.2%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the Jul 31 close.
Traded Fri, Jun 12. Filed Tue, Jun 16, 5:26 PM ET, after the close. Returns use the Jun 17 open and the Jul 31 close. Not investment advice.